Level Bio AB (publ) (NGM:LEVBIO)
Sweden
· Delayed Price · Currency is SEK 0.3440
-0.0140 (-3.91%)
At close: Jun 30, 2025
Level Bio AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 27.4 | 25.1 | 26.1 | 34.33 | 43.96 | 23.53 | Upgrade
| |
Revenue Growth (YoY) | 18.11% | -3.83% | -23.99% | -21.91% | 86.86% | 37.77% | Upgrade
|
Cost of Revenue | 12.89 | 11.6 | 13.79 | 19.08 | 26.08 | 14.39 | Upgrade
|
Gross Profit | 14.51 | 13.49 | 12.31 | 15.25 | 17.88 | 9.14 | Upgrade
|
Selling, General & Admin | 18.85 | 19.6 | 20.33 | 15.87 | 12.05 | 7.56 | Upgrade
|
Other Operating Expenses | -0.07 | -0.21 | -0.48 | -0.46 | -0.69 | -0.19 | Upgrade
|
Operating Expenses | 20.96 | 21.58 | 22.04 | 17.59 | 12.62 | 7.59 | Upgrade
|
Operating Income | -6.45 | -8.08 | -9.73 | -2.33 | 5.26 | 1.55 | Upgrade
|
Interest Expense | -0.14 | -0.13 | -0.01 | -0.08 | -0.04 | -0.03 | Upgrade
|
Interest & Investment Income | 0.01 | 0.02 | 0.05 | 0 | - | 0 | Upgrade
|
Other Non Operating Income (Expenses) | - | - | - | - | - | -0 | Upgrade
|
EBT Excluding Unusual Items | -6.58 | -8.19 | -9.69 | -2.41 | 5.21 | 1.52 | Upgrade
|
Pretax Income | -6.58 | -8.19 | -9.69 | -2.41 | 5.21 | 1.52 | Upgrade
|
Income Tax Expense | -0.32 | -0.32 | -0.22 | -0.19 | 0.06 | 0.01 | Upgrade
|
Net Income | -6.25 | -7.87 | -9.48 | -2.22 | 5.16 | 1.51 | Upgrade
|
Net Income to Common | -6.25 | -7.87 | -9.48 | -2.22 | 5.16 | 1.51 | Upgrade
|
Net Income Growth | - | - | - | - | 240.69% | - | Upgrade
|
Shares Outstanding (Basic) | 63 | 63 | 63 | 63 | 59 | 53 | Upgrade
|
Shares Outstanding (Diluted) | 63 | 65 | 63 | 63 | 63 | 53 | Upgrade
|
Shares Change (YoY) | - | 2.96% | - | - | 20.00% | - | Upgrade
|
EPS (Basic) | -0.10 | -0.12 | -0.15 | -0.04 | 0.09 | 0.03 | Upgrade
|
EPS (Diluted) | -0.10 | -0.12 | -0.15 | -0.04 | 0.08 | 0.03 | Upgrade
|
EPS Growth | - | - | - | - | 179.27% | - | Upgrade
|
Free Cash Flow | -3.38 | -4.46 | -5.49 | 2.79 | 1.63 | 1.84 | Upgrade
|
Free Cash Flow Per Share | -0.05 | -0.07 | -0.09 | 0.04 | 0.03 | 0.04 | Upgrade
|
Gross Margin | 52.96% | 53.77% | 47.16% | 44.43% | 40.67% | 38.83% | Upgrade
|
Operating Margin | -23.55% | -32.21% | -37.30% | -6.79% | 11.96% | 6.58% | Upgrade
|
Profit Margin | -22.82% | -31.37% | -36.31% | -6.48% | 11.73% | 6.43% | Upgrade
|
Free Cash Flow Margin | -12.33% | -17.78% | -21.03% | 8.14% | 3.70% | 7.82% | Upgrade
|
EBITDA | -5.3 | -6.94 | -8.58 | -1.19 | 5.91 | 1.76 | Upgrade
|
EBITDA Margin | -19.35% | -27.65% | -32.87% | -3.48% | 13.45% | 7.48% | Upgrade
|
D&A For EBITDA | 1.15 | 1.14 | 1.15 | 1.14 | 0.65 | 0.21 | Upgrade
|
EBIT | -6.45 | -8.08 | -9.73 | -2.33 | 5.26 | 1.55 | Upgrade
|
EBIT Margin | -23.55% | -32.21% | -37.30% | -6.79% | 11.96% | 6.58% | Upgrade
|
Effective Tax Rate | - | - | - | - | 1.09% | 0.46% | Upgrade
|
Revenue as Reported | 27.41 | 25.18 | 26.67 | 34.68 | 44.65 | 23.71 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.